Get Flat 20% Discount on All Medications
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Marsing to market products of 6 Indian Pharma Cos in Europe

      Bangalore: Denmark-based Pharmaceutical marketing and distributing company, Marsing, will take up marketing of products of six major Indian Pharma Companies in Europe, besides Hikal, which had a majority stake in it.

      Marsing Chairman Jai Hiremath, also the Vice-Chairman and Managing Director of Hikal Ltd, told newspersons here that Marsing had made good progress in getting regulatory approvals for Hikal's Active Pharmaceutical Ingredients (APIs) in Europe and was in advanced discussions with other Indian Pharmaceutical companies to distribute their APIs, hospital injectables and veterinary formulations in the European market.

      Hikal had also recently acquired a minority stake in the subsidiary of 28 billion Dollar Sinochem, a Chinese pharma major.

      Marsing would not only have direct marketing of products from Sinochem in Europe, but also sell products routed through Hikal by Sinochem.

      Hikal had in September 2004 acquired 50.1 per cent shareholding in Marsing for a consideration of six million Dollars. The acquisition was partly funded by internal accruals and partly by the Exim Bank. However, Hikal had settled the Exim Bank loan through a Foreign Currency Convertible Bond issue, under which the company had diluted its stake to 68 per cent from 75 per cent, Mr Hiremath said.

      Marsing also had a 100 per cent French subsidiary Intsel Chimos which was marketing finished dosage in France. The first European regulatory approval for oncology pain management and anti-emesis APi/formulation was likely to come through from France and Germany by April this year, he informed.

      Mr Hiremath said Hikal's Rs.25 crore new contract research facility near Pune would go on stream by the end of 2006. The facility would have 25 scientists initially for contract research for pharma, biotech, agro and speciality chemical companies and the number would reach 250 scientists finally, he added.

      January 24, 2006


      Share this Article!

    Back to top^